Investing Profile

Andrew Hack

InvestorVC
Partner at Bain Capital
baincapital.comBoston, Massachusetts
Photo of Andrew Hack, Partner at Bain Capital Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4900 CONNECTIONS
Hotmail Network
4900 CONNECTIONS
Bain Capital Network
275 CONNECTIONS
University of Chicago Network
109 CONNECTIONS
University of Chicago Network
109 CONNECTIONS
cb
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Merida Biosciences
Series AApr 2025$120M
$120M
Co-investors: Sherry Chao (GV (Google Ventures)), Reid Huber (Third Rock Ventures), Abbie Celniker (Third Rock Ventures)
JenaValve Technology
Series CAug 2022$100M
Series UnknownFeb 2020$50M
$270M
Co-investors: Olivier Litzka (Andera Partners), Peter Barrett (Atlas Venture)
Nuvalent
Series BMay 2021$140M
$190M
Co-investors: Cameron Wheeler (Deerfield Management)
Xilio Therapeutics
Series CFeb 2021$95M
$330M
Co-investors: Mike Ross (SV Health Investors), Peter Dudek (M Ventures (Merck)), Jayson Punwani (Abingworth), Nancy Hong (San Diego Symphony), Jack Kenney (SV Health Investors)
Affinivax
Series CJan 2021$230M
Series BApr 2020$120M
$350M
Co-investors: Dorothy Margolskee (Foresite Capital)
Atea Pharmaceuticals
Series DMay 2020$220M
$220M
Director of Life Sciences Reify CorporationPresent
Biotechnology Analyst HotmailPresent
Principal MPM BioImpactPresent
Analyst HotmailPresent
Portfolio Manager MillenniumPresent
Chief Financial Officer Editas MedicinePresent
Partner Bain CapitalPresent
University of Chicago A.B. Biology
University of Chicago Ph.D. Molecular Genetics and Cell Biology
University of Chicago - The Pritzker School of Medicine M.D. Medicine